Delivery Order SPE2DB22D3301-SPE2DB25FZ0KT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Premarin 0.625 mg tablets in quantities of 100, with a contract ceiling value of $3,141.71. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,385.11 to AmerisourceBergen Drug Corp for 1,000 tablets of Premarin 0.3 mg, a hormone replacement therapy medication. This non-set-aside contract was competitively awarded with a firm fixed price structure and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,251.80 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified vendors. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100 units, with a ceiling value of $1,417.13 and an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- The Defense Logistics Agency awarded a $1,040.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Premarin 0.3 mg tablets (100-count units). This non-set-aside contract was competitively awarded and is scheduled for completion by August 20, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Premarin 0.625 mg tablets in quantities of 100 with a ceiling value of $1,023.73. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Premarin 0.625 mg tablets (100-count units) with a contract ceiling value of $1,490.37. This firm fixed-price delivery order, which is expected to be completed by August 4, 2025, represents a non-competitive set-aside arrangement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Premarin 0.3 mg tablets (100-count units) with a ceiling value of $4,722.10. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for ultimate completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.28 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on July 24, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by July 25, 2025, with work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Premarin is a conjugated estrogen hormone replacement therapy...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0KTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg with a ceiling value of $1,052.49. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. Through this prime vendor arrangement, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with pharmaceutical products across multiple therapeutic domains, positioning the company as a critical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/3/25 |